Clinical value of assessing serum levels of inflammatory cytokines in the early diagnosis of patients with primary liver carcinoma: a retrospective observational study

[1]  G. Torzilli,et al.  Tumor microenvironment in primary liver tumors: A challenging role of natural killer cells , 2020, World journal of gastroenterology.

[2]  S. Kaneko,et al.  Clinical Features and Dynamics of T Cells-Related Markers in Immunocompetent Patients with Cytomegalovirus Hepatitis , 2020, Canadian journal of gastroenterology & hepatology.

[3]  Mingyue Zhu,et al.  Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma , 2020, Journal of Cancer Research and Clinical Oncology.

[4]  J. Damoiseaux.  The IL-2 - IL-2 receptor pathway in health and disease: the role of the soluble IL-2 receptor. , 2020, Clinical immunology.

[5]  M. Mahtab,et al.  Increased Proinflammatory Cytokine Production by Chronic Hepatitis B Patients with Mutant Hepatitis B Virus: Plausible Mechanisms Underlying Severe Liver Diseases in These Patients. , 2020, Viral immunology.

[6]  M. Hino,et al.  Clinical usefulness of very high serum soluble interleukin-2 receptor levels for the detection of tuberculous peritonitis in a patient with chronic myelogenous leukemia. , 2020, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[7]  V. Ellenrieder,et al.  Association of serum interleukin-6 and soluble interleukin-2-receptor levels with disease activity status in patients with inflammatory bowel disease: A prospective observational study , 2020, PloS one.

[8]  B. Carr,et al.  Gamma glutamyl transpeptidase as a prognostic biomarker in hepatocellular cancer patients especially with >5 cm tumors, treated by liver transplantation , 2020, The International journal of biological markers.

[9]  Weifan Zheng,et al.  TNFAIP8 regulates autophagy, cell steatosis, and promotes hepatocellular carcinoma cell proliferation , 2020, Cell Death & Disease.

[10]  K. Awai,et al.  Individual Optimization of Contrast Media Injection Protocol at Hepatic Dynamic Computed Tomography Using Patient-Specific Contrast Enhancement Optimizer , 2020, Journal of computer assisted tomography.

[11]  [Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)]. , 2020 .

[12]  M. Kumar,et al.  Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission , 2019, The Lancet Gastroenterology & Hepatology.

[13]  E. Sagnelli,et al.  Epidemiological and etiological variations in hepatocellular carcinoma , 2019, Infection.

[14]  R. Ray,et al.  Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis , 2019, Cells.

[15]  Hong Lu,et al.  Hyperactivated peripheral invariant natural killer T cells correlate with the progression of HBV‐relative liver cirrhosis , 2019, Scandinavian journal of immunology.

[16]  Yu Chen,et al.  Hepatitis B e Antigen Inhibits NF-κB Activity by Interrupting K63-Linked Ubiquitination of NEMO , 2018, Journal of Virology.

[17]  Myeong-Jin Kim,et al.  Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial , 2018, BMC Cancer.

[18]  Zongchang Song,et al.  Circulating regulatory Tfh cells are enriched in patients with chronic hepatitis B infection and induce the differentiation of regulatory B cells , 2018, Experimental cell research.

[19]  Yunching Chen,et al.  A multifunctional nanocarrier for efficient TRAIL‐based gene therapy against hepatocellular carcinoma with desmoplasia in mice , 2018, Hepatology.

[20]  Di Chen,et al.  Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice. , 2017, Journal of hepatology.

[21]  W. Lau,et al.  Impact of Preoperative Hepatitis B Virus Levels on Prognosis After Primary and Repeat Hepatectomies for Hepatocellular Carcinoma Patients—a Retrospective Study , 2018, Journal of Gastrointestinal Surgery.

[22]  Jen-Leih Wu,et al.  Inducible liver-specific overexpression of gankyrin in zebrafish results in spontaneous intrahepatic cholangiocarcinoma and hepatocellular carcinoma formation. , 2017, Biochemical and biophysical research communications.

[23]  Lanjuan Li,et al.  CD4+CD25+ regulatory T-cells: a potential target for treating patients with chronic HBV infection , 2017, Cellular and Molecular Immunology.

[24]  C. Rice,et al.  Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons. , 2017, Gastroenterology.

[25]  M. Heikenwalder,et al.  Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus Replication , 2017, Cellular and molecular gastroenterology and hepatology.

[26]  S. Nie,et al.  The predictive value of integrated inflammation scores in the survival of patients with resected hepatocellular carcinoma: A Retrospective Cohort Study. , 2017, International journal of surgery.

[27]  Ken‐ichiro Yoshida,et al.  Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy , 2017, BMC Cancer.

[28]  Z. Tian,et al.  HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production. , 2017, Journal of hepatology.

[29]  A. Roccaro,et al.  Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myeloma , 2016, Current opinion in hematology.

[30]  C. Shou,et al.  Tumor Necrosis Factor-A Polymorphisms and Colorectal Cancer Risk: A Meta-Analysis , 2014, PloS one.

[31]  J. Pober,et al.  Tumour necrosis factor in infectious disease , 2013, The Journal of pathology.

[32]  Jianguo Wu,et al.  Hepatitis B Virus Induces a Novel Inflammation Network Involving Three Inflammatory Factors, IL-29, IL-8, and Cyclooxygenase-2 , 2011, The Journal of Immunology.

[33]  P. Revill,et al.  The hepatitis B e antigen suppresses IL‐1β‐mediated NF‐κB activation in hepatocytes , 2011, Journal of viral hepatitis.

[34]  L. Roberts,et al.  The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. , 2011, Seminars in cancer biology.

[35]  S. Cairo,et al.  The Hepatitis B Virus X Protein Functionally Interacts with CREB-binding Protein/p300 in the Regulation of CREB-mediated Transcription* , 2007, Journal of Biological Chemistry.